Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells.

G Upadhyaya; S C Guba; S A Sih; A P Feinberg; M Talpaz; H M Kantarjian; A B Deisseroth; S G Emerson

doi:10.1172/JCI115543

Department of Internal Medicine, University of Michigan, Ann Arbor 48109.

Find articles by Upadhyaya, G. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Michigan, Ann Arbor 48109.

Find articles by Guba, S. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Michigan, Ann Arbor 48109.

Find articles by Sih, S. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Michigan, Ann Arbor 48109.

Find articles by Feinberg, A. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Michigan, Ann Arbor 48109.

Find articles by Talpaz, M. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Michigan, Ann Arbor 48109.

Find articles by Kantarjian, H. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Michigan, Ann Arbor 48109.

Find articles by Deisseroth, A. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Michigan, Ann Arbor 48109.

Find articles by Emerson, S. in: JCI | PubMed | Google Scholar

Published in Volume 88, Issue 6 on December 1, 1991
J Clin Invest. 1991;88(6):2131–2136. https://doi.org/10.1172/JCI115543.
© 1991 The American Society for Clinical Investigation

Published December 1, 1991 - Version history

Hematopoietic cells from the malignant clone in chronic myelogenous leukemia (CML) maintain and expand a proliferative advantage over normal hematopoietic cells within the bone marrow. This advantage is often ameliorated or reversed in vivo by IFN alpha. Based upon earlier studies suggesting decreased adhesiveness of CML progenitor cells, we asked whether CML progenitor cells are deficient in their expression of the cytoadhesion molecule lymphocyte function antigen-3 (LFA-3, CD58) which is normally expressed on hematopoietic progenitors. Progenitor cells from untreated CML patients showed greatly reduced or absent LFA-3 expression, whereas progenitors from patients treated with IFN alpha in vivo or in vitro expressed surface LFA-3 at more normal levels. LFA-3-deficient CML progenitor cells were unable to stimulate normal regulatory proliferative responses in autologous T cells. We hypothesize that IFN alpha-sensitive LFA-3 deficiency reflects a cell surface cytoadhesion defect which may help explain adhesive abnormalities of CML progenitor cells in vitro and clonal proliferation in vivo.

Images.

Version 1 (December 1, 1991): No description

Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells.

G Upadhyaya, S C Guba, S A Sih, A P Feinberg, M Talpaz, H M Kantarjian, A B Deisseroth, and S G Emerson

Article tools

Metrics

Go to

Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells.

G Upadhyaya, S C Guba, S A Sih, A P Feinberg, M Talpaz, H M Kantarjian, A B Deisseroth, and S G Emerson

Article tools

Metrics

Go to

Sign up for email alerts